Traditionally Unacceptable Organs Promote Liver Transplantation in Patients with Long Waiting Times in the Share 35 Era.
1Department of Surgery, University of Maryland School of Medicine, Baltimore, MD
2University of Maryland Medical Center, Baltimore, MD.
Meeting: 2016 American Transplant Congress
Abstract number: 106
Keywords: Allocation, Hepatocellular carcinoma, High-risk
Session Information
Session Name: Concurrent Session: Hepatic Malignancies
Session Type: Concurrent Session
Date: Sunday, June 12, 2016
Session Time: 4:30pm-6:00pm
Presentation Time: 4:54pm-5:06pm
Location: Room 304
Hepatocellular carcinoma (HCC) remains the most commonly granted MELD exception (M/E). Share 35 has disadvantaged this population. We have developed a strategy to use traditionally unacceptable organs (TUOs) including locally discarded organs, grafts with macrosteatosis, and DCD donors for these recipients.
Methods:
A retrospective review of the patients transplanted for HCC in a large urban academic medical center was performed from 1/2012-8/2015. Recipient and Donor data were obtained from our databases. Longitudinal follow-up has been maintained for recurrence of HCC. M/E at transplant, time to transplant, donor origin and organ type were analyzed.
Results:
In 2012, 30% of patients were transplanted under an HCC M/E. They had an average waitlist time of 435 days and 85% of the grafts were from local donors. After Share 35, the HCC M/E patients made up only 20% of the transplanted population with most of livers (85%) procured locally. This decreased to 15% with concomitant increase in the time to transplant. In 2015, with the use of TUOs for the HCC population we observed an increase in the percentage of M/E (30%) patients transplanted with a decrease in transplant time (213 days v. 311days, p=0.001). Regionally procured livers increased to 50% for the HCC M/E population. There was no change in the average MELD at transplant in the time periods analyzed (p=0.2).
Conclusion:
Liver transplantation in the Share 35 era disadvantages the HCC M/E population. An aggressive approach to the use of local and regional TUOs may increase in the number of M/E patients transplanted. This may lead to a reduction in waitlist time and a reduction in early disease recurrence.
Year | N=Liver Transplant for HCC | Ave. MELD at Transplant (p=0.2) | Ave. Wait time (days) p=0.001) | Import Livers (%) |
2012 | 26 | 24.6 | 435 | 4(15%) |
2013 | 17 | 26.2 | 262 | 3(18%) |
2014 | 17 | 27.5 | 311 | 4(23%) |
2015 | 28 | 27.2 | 213 | 14(50%) |
CITATION INFORMATION: Siskind E, MacDonald T, Barth R, LaMattina J, Bruno D, Hanish S. Traditionally Unacceptable Organs Promote Liver Transplantation in Patients with Long Waiting Times in the Share 35 Era. Am J Transplant. 2016;16 (suppl 3).
To cite this abstract in AMA style:
Siskind E, MacDonald T, Barth R, LaMattina J, Bruno D, Hanish S. Traditionally Unacceptable Organs Promote Liver Transplantation in Patients with Long Waiting Times in the Share 35 Era. [abstract]. Am J Transplant. 2016; 16 (suppl 3). https://atcmeetingabstracts.com/abstract/traditionally-unacceptable-organs-promote-liver-transplantation-in-patients-with-long-waiting-times-in-the-share-35-era/. Accessed November 22, 2024.« Back to 2016 American Transplant Congress